Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Samsung Biologics
Pharmaceutical Preparation ManufacturingSouth KoreaKSC: 207940.KS
Last verified 1 month agosamsungbiologics.com
Samsung Biologics, a leading player in the pharmaceutical preparation manufacturing industry, is headquartered in Incheon, South Korea (KR). Founded in 2011, the company has rapidly established itself as a key provider of contract development and manufacturing services (CDMO) for biopharmaceuticals, focusing on monoclonal antibodies and other biologics.
With state-of-the-art facilities and a commitment to innovation, Samsung Biologics offers unique solutions that streamline the drug development process, ensuring high-quality production standards. The company has achieved significant milestones, including the expansion of its manufacturing capacity and the successful completion of numerous projects for global clients. Recognised for its excellence, Samsung Biologics continues to strengthen its market position, contributing to advancements in the biopharmaceutical sector.
62
DitchCarbon score
+20 vs industry average
Samsung Biologics’s score of 62 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Samsung Biologics?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Samsung Biologics's reported carbon emissions
Samsung Biologics, headquartered in KR and operating in Pharmaceutical Preparation Manufacturing, reported total emissions of 636,209,000 kg CO2e in 2024. This includes 71,971,718 kg CO2e from Scope 1, 115,827,854 kg CO2e from Scope 2 (market-based), and 448,410,157 kg CO2e from Scope 3.
The company has set ambitious climate commitments, aiming for net-zero emissions by 2050 or earlier. This includes significant absolute reduction targets from a 2022 baseline:
- Scope 1 Emissions: A 32% reduction by 2030 and a 62% reduction by 2040.
- Supplier Emissions (Scope 3 related): A 36% reduction by 2030 and a 73% reduction by 2040.
In 2023, Samsung Biologics' total emissions were 696,378,000 kg CO2e, comprising 69,262,496 kg CO2e for Scope 1, 113,313,391 kg CO2e for Scope 2 (market-based), and 513,803,084 kg CO2e for Scope 3. This represents a decrease in total emissions from 2023 to 2024.
Looking back to 2022, total emissions stood at 946,205,000 kg CO2e, with Scope 1 at 54,575,447 kg CO2e, Scope 2 (market-based) at 99,917,630 kg CO2e, and Scope 3 at 791,712,059 kg CO2e. This indicates a notable reduction in overall emissions since 2022, the baseline year for their reduction targets.
Assessing Samsung Biologics as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Samsung Biologics and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Samsung Biologics’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
11 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
2050 targetSee details
Active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Samsung Biologics1 month ago
62
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more